Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study

OBJECTIVE: Numerous studies have suggested a decreased risk of cancer in patients with diabetes on metformin. Because different comparison groups were used, the effect magnitude is difficult to estimate. Therefore, the objective of this study was to further analyze whether, and to what extent, use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiter, Rikje, Visser, Loes E., van Herk-Sukel, Myrthe P.P., Coebergh, Jan-Willem W., Haak, Harm R., Geelhoed-Duijvestijn, Petronella H., Straus, Sabine M.J.M., Herings, Ron M.C., Stricker, Bruno H.Ch.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241334/
https://www.ncbi.nlm.nih.gov/pubmed/22100960
http://dx.doi.org/10.2337/dc11-0857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241334/
https://www.ncbi.nlm.nih.gov/pubmed/22100960
http://dx.doi.org/10.2337/dc11-0857

Ejemplares similares